These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12022906)

  • 1. Insulin glargine: a new basal insulin.
    Levien TL; Baker DE; White JR; Campbell RK
    Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glargine.
    Campbell RK; White JR; Levien T; Baker D
    Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.
    Lam S
    Heart Dis; 2003; 5(3):231-40. PubMed ID: 12783637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin glargine: a new long-acting insulin product.
    Reinhart L; Panning CA
    Am J Health Syst Pharm; 2002 Apr; 59(7):643-9. PubMed ID: 11944604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
    Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
    Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
    Duckworth W; Davis SN
    J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
    McKeage K; Goa KL
    Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.
    McKeage K; Goa KL
    Drugs; 2001; 61(11):1599-624. PubMed ID: 11577797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insulins: expanding options in diabetes management.
    Gerich JE
    Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
    Owens DR; Bolli GB
    Diabetes Technol Ther; 2008 Oct; 10(5):333-49. PubMed ID: 18715209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR; Lurie A; Baldwin D
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.